Eli Lilly and Company’s LLY stock has declined 5.1% so far this month, despite announcing strong second-quarter results on ...

Rhythm Pharmaceuticals (NASDAQ:RYTM) announced that U.S. and EU regulators have accepted for review a potential label ...

Last year, GLP-1s dominated many employer conversations as demand surged and pressure mounted from employees clamoring for ...

Employers surveyed by the Business Group on Health are bracing for the largest annual increase in healthcare costs in more ...